BRCA1 and prostate carcinoma: Both the HRD-DNA model and the HRD-RNA model captured biallelic loss of BRCA1/2 with high sensitivity and specificity in BRCA-associated tumors (breast, ovarian, pancreatic, and prostate cancer) (Fig. 2B; Fig. 3B).